15 april 2024
22 min
Welcome to another episode with the DNB//Back Bay Partnership for Healthcare.
In this episode Jonathan Gertler, Back Bay CEO and Managing Partner, is once again joined by James Cirenza, Head of Fixed Income and Equities at DNB, Kristoffer Braaten, Director of US Equity Capital Markets at DNB, and Vasilios Kofitsas, Managing Director of Investment Banking at Back Bay Life Science Advisors, to talk about current market dynamics and the 2024 IPO outlook in the US and in Europe.
Topics in this podcast include:
As always we welcome listener questions and/or topics you’d like to learn more about.
You can listen to previous episodes here or submit your inquiries to info@bblsa.com.
Learn more about the DNB//Back Bay Partnership and read our disclaimers at https://www.bblsa.com/dnb-back-bay-partnership.
Lyssna på fler avsnitt från
Back Bay Life Science Report
Visar 1–10 av 34 avsnitt
15 april 2026
30 min
5 mars 2026
30 min
9 februari 2026
29 min
7 februari 2025
16 min
8 november 2024
27 min
30 september 2024
21 min
16 september 2024
28 min
22 maj 2024
35 min
30 april 2024
27 min
18 mars 2024
38 min